Sonpavde G, van der Heijden MS, Gupta S, Galsky MD, et al. Neoadjuvant nivolumab plus gemcitabine-cisplatin followed by postsurgical adjuvant nivolumab versus neoadjuvant gemcitabine-cisplatin in patients with muscle-invasive bladder cancer: final results from the phase III CA017-078 trial. Ann Oncol 2026 Dec 31:S0923-7534(26)06877-8. doi: 10.1016/j.annonc.2026.
PMID: 42918420